<DOC>
	<DOCNO>NCT00272844</DOCNO>
	<brief_summary>The purpose study determine whether supplementation oil-based cholesterol suspension correct biochemical abnormality cholesterol precursor individual Smith-Lemli-Opitz syndrome .</brief_summary>
	<brief_title>Treatment Cholesterol Defect Smith-Lemli-Opitz Syndrome</brief_title>
	<detailed_description>This study involve treat individual Smith-Lemli-Opitz syndrome , rare inborn error cholesterol metabolism , supplemental cholesterol determine effect biochemical sterol metabolite , growth , neuropsychological development , ophthalmologic auditory function , ERG ( electroretinogram ) parameter , CNS metabolite determine brain MRS-imaging . Safety supplemental cholesterol suspension monitor test hematologic , renal , liver function periodic interval . There also substudy investigate potential genotype-phenotype correlation , well another study biochemical parameter light sensitivity culture skin fibroblast affect patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Hypertelorism</mesh_term>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<criteria>Biochemical confirmation sterol defect associate SmithLemliOpitz syndrome Inability tolerate crystalline cholesterol Inability travel Boston 34 times/year base age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>cholesterol</keyword>
	<keyword>Smith-Lemli-Opitz syndrome</keyword>
	<keyword>mental retardation</keyword>
	<keyword>sterol</keyword>
	<keyword>congenital anomaly</keyword>
</DOC>